BamSEC and AlphaSense Join Forces
Learn More

DiaMedica Therapeutics Inc.

NASDAQ: DMAC    
Share price (1/3/25): $5.56    
Market cap (1/3/25): $238 million
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.2
from 8-K 15 pages Registration Rights Agreement
12/34/56
EX-10.1
from 8-K 39 pages Securities Purchase Agreement
12/34/56
EX-10.1
from 8-K 27 pages DiaMedica Therapeutics Inc. Amended and Restated 2019 Omnibus Incentive Plan
12/34/56
EX-10.23
from 10-K 2 pages Third Amendment to Gpex® Development and Manufacturing Agreement
12/34/56
EX-10.2
from 8-K 13 pages Separation Agreement and Release
12/34/56
EX-10.1
from 8-K 6 pages Consulting Services Agreement
12/34/56
EX-10.2
from 8-K 15 pages Registration Rights Agreement
12/34/56
EX-10.1
from 8-K 39 pages Securities Purchase Agreement
12/34/56
EX-10.17
from 10-K 28 pages Employment Agreement
12/34/56
EX-10.2
from 8-K 3 pages Lease Guaranty Agreement
12/34/56
EX-10.1
from 8-K 55 pages 301 Carlson Parkway Office Lease Between Medica Services Company, LLC a Delaware Limited Liability Company as Landlord and DiaMedica USA Inc., a Delaware Corporation as Tenant
12/34/56
EX-10.2
from 8-K 6 pages Consulting Services Agreement
12/34/56
EX-10.1
from 8-K 13 pages Separation Agreement and Release
12/34/56
EX-10.1
from 8-K 28 pages DiaMedica Therapeutics Inc. Amended and Restated 2019 Omnibus Incentive Plan
12/34/56
EX-10.6
from 10-K 8 pages Notice of Option Grant Under the DiaMedica Therapeutics Inc. 2021 Employee Inducement Incentive Plan
12/34/56
EX-10.5
from 10-K 27 pages DiaMedica Therapeutics Inc. 2021 Employment Inducement Incentive Plan
12/34/56
EX-10.2
from 10-K 8 pages Notice of Option Grant Under the DiaMedica Therapeutics Inc. 2019 Omnibus Incentive Plan
12/34/56
EX-10.2
from 8-K 15 pages Registration Rights Agreement
12/34/56
EX-10.1
from 8-K 48 pages Securities Purchase Agreement
12/34/56
EX-10.1
from 10-Q 8 pages Notice of Deferred Stock Unit Grant Under the DiaMedica Therapeutics Inc. 2019 Omnibus Incentive Plan
12/34/56